Home › Funds › Fidelity › Fidelity Small Cap Growth Index Fund
Fund family: Fidelity · Filed by FIDELITY SALEM STREET TRUST (CIK 35315) · SEC series S000065750
Ticker: FECGX (C000212598)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 8,535 with, 29 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 6 FOR, 12 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Fidelity’s manager page (1,165,189 ballot items across 406 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Fidelity | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 95.8% | 8,271 | 94.1% | 974,562 |
| Backed environmental and social shareholder proposals at US companies | n/a | 4 | 6.8% | 11,096 |
Each ballot item this fund voted is set against the votes of the other Fidelity funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Fidelity funds on 41 items (0.5% of the 8,368 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Fidelity funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| BETA Technologies, Inc. | 2026-06-11 | Election of Directors: John Abele | Withhold | FOR — 38 of 43 Fidelity funds | Against | — |
| BrightSpring Health Services, Inc. | 2026-05-21 | Election of Class II directors: Max Lin | For | WITHHOLD — 35 of 47 Fidelity funds | For | Passed (calculated), 76.3% support |
| NovaGold Resources Inc. | 2026-05-14 | Approval of Non-Binding Advisory Vote on Executive Compensation To consider and, if deemed advisable, pass a non-binding resolution approving the compensation of the Company's Named Executive Officers. | For | AGAINST — 14 of 17 Fidelity funds | For | Approved, 72.5% support |
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatio | Against | FOR — 28 of 40 Fidelity funds | Against | Passed (calculated), 86.6% support |
| Construction Partners, Inc. | 2026-03-24 | Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Craig Jennings | For | WITHHOLD — 32 of 46 Fidelity funds | For | Passed (calculated), 79.8% support |
| Sanmina Corporation | 2026-03-09 | To approve, on an advisory (non-binding) basis, the compensation of Sanmina Corporation's named executive officers. | For | AGAINST — 34 of 51 Fidelity funds | For | Passed (calculated), 81.4% support |
| OUTFRONT Media Inc. | 2026-06-03 | Election of Director Nominees: Susan M. Tolson | Against | FOR — 26 of 39 Fidelity funds | Against | Passed (calculated), 66.4% support |
| Warby Parker Inc. | 2026-06-08 | Election of Directors: Ronald Williams | Withhold | FOR — 23 of 34 Fidelity funds | Against | Elected, 91.5% support |
| Sanmina Corporation | 2026-03-09 | To elect eight directors of Sanmina Corporation: David V. Hedley III | For | AGAINST — 30 of 47 Fidelity funds | For | Passed (calculated), 83.5% support |
| Sanmina Corporation | 2026-03-09 | To elect eight directors of Sanmina Corporation: Joseph G. Licata, Jr. | For | AGAINST — 30 of 47 Fidelity funds | For | Passed (calculated), 81.5% support |
| Sanmina Corporation | 2026-03-09 | To elect eight directors of Sanmina Corporation: Susan A. Johnson | For | AGAINST — 30 of 47 Fidelity funds | For | Passed (calculated), 83.4% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 26 of 40 Fidelity funds | Against | Approved, 61.7% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Dr. Kennon H. Guglielmo | For | WITHHOLD — 28 of 44 Fidelity funds | For | Passed (calculated), 78.3% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Raymond J. Chess | For | WITHHOLD — 28 of 44 Fidelity funds | For | Passed (calculated), 77.9% support |
| Rush Enterprises, Inc. | 2026-05-19 | Election of Directors: Troy A. Clarke | For | WITHHOLD — 28 of 44 Fidelity funds | For | Passed (calculated), 78.3% support |
| IMAX Corporation | 2026-06-10 | 4 wordings Election of Directors Election of the ten nominees for the Board of Directors: Gail Berman | For | AGAINST — 8 of 10 Fidelity funds | For | Passed (calculated), 92.5% support |
| Tecnoglass Inc. | 2026-06-16 | To elect three Class A directors to serve for the ensuing three-year period until their successors are elected and qualified: Anne Louise Carricarte | Against | FOR — 19 of 28 Fidelity funds | Against | Passed (calculated), 82.3% support |
| Alignment Healthcare, Inc. | 2026-06-04 | Election of Directors: David Hodgson | Withhold | FOR — 23 of 35 Fidelity funds | Against | Elected, 60.8% support |
| LifeStance Health Group, Inc. | 2026-06-02 | Election of two director nominees named in the Proxy Statement to serve until the 2029 Annual Meeting of Stockholders: David Bourdon | For | WITHHOLD — 25 of 39 Fidelity funds | For | Elected, 74.5% support |
| Tecnoglass Inc. | 2025-12-19 | Advisory approval of the compensation for our named executive officers. | Against | FOR — 22 of 34 Fidelity funds | Against | Approved, 77.5% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Daniel Muniz Quintanilla | For | WITHHOLD — 10 of 14 Fidelity funds | For | Elected, 91.4% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Dr. Elaine Dorward-King | For | WITHHOLD — 10 of 14 Fidelity funds | For | Elected, 91.5% support |
| NovaGold Resources Inc. | 2026-05-14 | Election of Directors: Kalidas Madhavpeddi | For | WITHHOLD — 10 of 14 Fidelity funds | For | Elected, 88.8% support |
| Insight Enterprises, Inc. | 2026-05-13 | Advisory vote (non-binding) to approve named executive officer compensation. | For | AGAINST — 22 of 39 Fidelity funds | For | Passed (calculated), 86.7% support |
| Kestra Medical Technologies, Ltd. | 2025-09-03 | The election of Conor Hanley and Elizabeth Kwo to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Conor Hanley | For | AGAINST — 13 of 21 Fidelity funds | For | — |
| Company | Meeting | Item | This fund | Most Fidelity funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. | 2025-09-03 | The election of Conor Hanley and Elizabeth Kwo to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified: Elizabeth Kwo | For | AGAINST — 13 of 21 Fidelity funds | For | — |
| Immunovant, Inc. | 2025-08-27 | To elect as directors the three nominees named in the Company's proxy statement, each to hold office until our 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Douglas Hughes | Withhold | FOR — 16 of 28 Fidelity funds | Against | Elected, 89.5% support |
| Stoke Therapeutics, Inc. | 2026-06-03 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | For | AGAINST — 17 of 30 Fidelity funds | For | Passed (calculated), 72.9% support |
| Mineralys Therapeutics, Inc. | 2026-05-21 | Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H. | For | WITHHOLD — 15 of 26 Fidelity funds | For | Passed (calculated), 63.3% support |
| Shoulder Innovations, Inc. | 2026-06-26 | The election of the Class I directors: Robert Ball | For | WITHHOLD — 9 of 14 Fidelity funds | For | — |
| Stoke Therapeutics, Inc. | 2026-06-03 | Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Adrian Krainer, Ph.D. | For | WITHHOLD — 15 of 27 Fidelity funds | For | Passed (calculated), 73.0% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: James E. Nave, D.V.M. | For | WITHHOLD — 16 of 30 Fidelity funds | For | Elected, 96.6% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Robert E. Lewis | For | WITHHOLD — 16 of 30 Fidelity funds | For | Elected, 96.2% support |
| TeraWulf Inc. | 2026-06-09 | Election of directors: Steven Pincus | For | WITHHOLD — 15 of 28 Fidelity funds | For | Elected, 92.2% support |
| Flowco Holdings Inc. | 2026-05-07 | The election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders and until his/her successors are duly elected and qualified: Joseph R. Edwards | Withhold | FOR — 8 of 13 Fidelity funds | Against | Elected, 98.4% support |
| IonQ, Inc. | 2026-06-16 | To approve, on an advisory basis, the compensation of our named executive officers in 2025. | For | AGAINST — 12 of 22 Fidelity funds | For | Approved, 53.7% support |
| Arrowhead Pharmaceuticals, Inc. | 2026-03-19 | Advisory Vote to Approve Executive Compensation. | For | AGAINST — 13 of 24 Fidelity funds | For | — |
| Workiva Inc. | 2026-05-28 | Election of Directors: Michael M. Crow, Ph.D. | Withhold | FOR — 13 of 24 Fidelity funds | Against | Passed (calculated), 77.9% support |
| Stoke Therapeutics, Inc. | 2026-06-03 | Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne Smith | For | WITHHOLD — 14 of 27 Fidelity funds | For | Passed (calculated), 86.9% support |
| Tenable Holdings, Inc. | 2026-05-13 | To elect the Board of Directors' nominees, John C. Huffard, Jr., A. Brooke Seawell, and Raymond Vicks, Jr., to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: John C. Huffard, Jr. | For | WITHHOLD — 12 of 23 Fidelity funds | For | Elected, 54.4% support |
| UroGen Pharma Ltd. | 2026-06-22 | To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law. | Against | FOR — 5 of 9 Fidelity funds | Against | Approved, 68.2% support |
Download all 41 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 89.2% of this fund’s 8,564 such votes could be given a sector; the other 925 (10.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 1,834 | 10 | 0.5% |
| Consumer Discretionary | 1,397 | 7 | 0.5% |
| Finance | 1,215 | 0 | 0.0% |
| Technology | 1,078 | 3 | 0.3% |
| Industrials | 887 | 3 | 0.3% |
| Real Estate | 257 | 0 | 0.0% |
| Energy | 250 | 0 | 0.0% |
| Utilities | 175 | 0 | 0.0% |
| Miscellaneous | 169 | 0 | 0.0% |
| Consumer Staples | 130 | 4 | 3.1% |
| Telecommunications | 124 | 1 | 0.8% |
| Basic Materials | 123 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 5,726 | 11 |
| Audit-related | 1,064 | 0 |
| Say-on-Pay | 1,034 | 2 |
| Compensation | 359 | 0 |
| Corporate Governance | 244 | 9 |
| Capital Structure | 125 | 2 |
| Extraordinary Transactions | 99 | 0 |
| Shareholder Rights and Defenses | 22 | 1 |
| Other | 10 | 0 |
| Diversity, Equity, and Inclusion | 2 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $30M | 8 | 0 |
| agilon health, inc. | March 17, 2026 | $28M | 2 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $14M | 5 | 0 |
| Glaukos Corporation | May 28, 2026 | $10M | 4 | 0 |
| BridgeBio Pharma, Inc. | June 22, 2026 | $9M | 7 | 0 |
| The Ensign Group, Inc. | May 13, 2026 | $8M | 6 | 0 |
| Watts Water Technologies, Inc. | May 19, 2026 | $8M | 11 | 0 |
| Semtech Corporation | June 4, 2026 | $7M | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| May 20, 2026 | Lumen Technologies, Inc. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | For | Against |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | Against | For |
| June 3, 2026 | Power Integrations, Inc. | To consider, if properly presented at the Annual Meeting, a stockholder proposal related to the separation of the office of Chairman of the Board and the office of Chief Executive Officer. Shareholder proposal | Against | For |
| May 7, 2026 | Wolverine World Wide, Inc. | Shareholder proposal regarding new climate change polices or practices. Shareholder proposal | Against | For |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
| May 12, 2026 | Group 1 Automotive, Inc. | Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposal | Against | For |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of Directors: Ortelius Nominees OPPOSED by the Company: Steven J. Insoft Shareholder proposal | Withhold | For |
| July 11, 2025 | Brookdale Senior Living Inc. | Election of Directors: Ortelius Nominees OPPOSED by the Company: Paula J. Poskon Shareholder proposal | Withhold | For |
| April 22, 2026 | Bloomin' Brands, Inc. | Stockholder Proposal Regarding Disclosure of Employee Retention Demographics Shareholder proposal | Against | For |
| April 22, 2026 | Bloomin' Brands, Inc. | Stockholder Proposal Regarding the Issuance of "Blank-Check" Preferred Stock Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (8 in 2025-2026), and how the fund voted the items on its ballot.
8,688 ballot items at 1,180 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Fidelity Small Cap Growth Index Fund (FECGX) voted at 1,180 shareholder meetings of 1,112 companies, on 8,688 ballot items in all. Where management made a recommendation, the fund followed it on 99.7% of the items and voted against it 29 times. Its most frequent area of disagreement was director elections (11 of its votes against management). It voted on 29 shareholder proposals. It voted FOR the board's own proposals more often than Fidelity's funds as a whole (95.8% against 94.1%). It voted differently from most Fidelity funds on 41 items. 8 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Fidelity’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.